InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,972.43
(
0.29%
)
Post# of 14825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

darcie

Send PM Follow Ignore
Followers 2
Posts 87
Boards Moderated 0
Alias Born 10/02/2010

darcie

Re: None

Thursday, 03/03/2011 1:01:04 PM

Thursday, March 03, 2011 1:01:04 PM

Post# of 14825
News --Located in Portland, Oregon, Calypte Biomedical gained recognition by developing in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection and other sexually transmitted chronic diseases. Today, Calypte Biomedic took a major step towards prominence with the announcement they have successfully completed internal studies of its new Aware HIV-1/2 oral fluid rapid test for the US and international markets.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up